imagine if JF decides to take the drug all the way through phase 3 swiftly and directly apply for FDA approval. I don’t see any concerns with fast track approval due to salvage therapy and reduced side effects. Such a shame that the future funds does not invest/buy out promising Australian companies, unlike the Singaporean sovereign funds: Temasek and GIC. I don’t even want to imagine the amount of cash generated by one of these DEP drug each year, would be multiple of the current SPL market CAP.
ALL the potential wasted because we are stuck with JF, also I don’t know why she is also the sole inventor of some Patents from SPL. Surely she doesn’t work in the lab? How could she be the sole inventor of any IP? Does someone know anyone working in SPL? I would love to hear their opinion on their CEO
- Forums
- ASX - By Stock
- Ann: DEP docetaxel and gemcitabine combination trial commences
imagine if JF decides to take the drug all the way through phase...
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
-0.002(2.11%) |
Mkt cap ! $38.35M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.3¢ | $48.64K | 512.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 153365 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 153365 | 0.093 |
1 | 60000 | 0.092 |
1 | 5000 | 0.090 |
1 | 50000 | 0.089 |
2 | 147200 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 65000 | 1 |
0.099 | 56700 | 2 |
0.100 | 111205 | 3 |
0.105 | 146531 | 5 |
0.110 | 43099 | 6 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
SPL (ASX) Chart |